Cleared Traditional

GenePOC CDiff

K172569 · Genepoc, Inc. · Microbiology
Nov 2017
Decision
89d
Days
Class 2
Risk

About This 510(k) Submission

K172569 is an FDA 510(k) clearance for the GenePOC CDiff, a C. Difficile Toxin Gene Amplification Assay (Class II — Special Controls, product code OZN), submitted by Genepoc, Inc. (Quebec, CA). The FDA issued a Cleared decision on November 22, 2017, 89 days after receiving the submission on August 25, 2017. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3130.

Submission Details

510(k) Number K172569 FDA.gov
FDA Decision Cleared SESE
Date Received August 25, 2017
Decision Date November 22, 2017
Days to Decision 89 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code OZN — C. Difficile Toxin Gene Amplification Assay
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.3130
Definition Amplification Assay For The Detection Of C. Difficile Toxin Genes From Stool Specimens Of Symptomatic Patients.

Similar Devices — OZN C. Difficile Toxin Gene Amplification Assay

All 16
Xpert C. difficile/Epi
K243730 · Cepheid · Feb 2025
Great Basin Toxigenic C. difficile Direct Test (CDF2)
K232092 · Vela Operations USA · Nov 2023
cobas Cdiff nucleic acid test for use on the cobas Liat System
K212427 · Roche Molecular Systems, Inc. · Oct 2021
cobas Cdiff nucleic acid test for use on the cobas Liat System
K210385 · Roche Molecular Systems, Inc. · Sep 2021
cobas Cdiff Nucleic acid test for use on the cobas Liat System
K171770 · Roche Molecular Systems, Inc. · Sep 2017
ARIES C. difficile Assay Complete Kit, ARIES C. difficile Assay Protocol File Kit, ARIES C. difficile Assay Kit (24 cassettes), ARIES Stool Resuspension Kit
K171441 · Luminex Corporation · Jul 2017